Cell No. : Cell Name
RCB5982 : HCT116 CERT1 KO/mVenus-CERT dupAA
update : 2024/07/18
|
| Comment | Currently not ready. |
| Comment from the depositor | The parental HCT116 CERT1 KO is a CERT1-disrupted derivative of the HCT 116 cell line, derived from human colon cancer. HCT116 CERT1 KO/mVenus-CERT dupAA cells represent a batch of HCT116 CERT1 KO-derived cells that stably express mVenus-fused human CERT dupAA-frameshift mutant using the retroviral vector pMXs-IB. This batch consists of a mixture of blasticidin S-resistant cells that were not cloned. |
| Terms and conditions | |
| Remarks | |
| Order Form |
|
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
|
|
Basic information
|
Expected time |
Upon a request we will start preparation. Contact us: cellkitaku.brc@riken.jp
|
| IPR |
National Institute of Infectious Diseases (Japan)
|
| Depositor |
HANADA, Kentaro
|
| Reference information |
Reference |
2
|
| User's Publication |
0
|
| Reference |
|
21780
Tamura N, Sakai S, Martorell L, Colomé R, Mizuike A, Goto A, Ortigoza-Escobar JD, Hanada K.
Intellectual disability-associated mutations in the ceramide transport protein gene CERT1 lead to aberrant function and subcellular distribution.
J Biol Chem
2021
101338
PubMed ID: 34688657
DOI: 10.1016/j.jbc.2021.101338
|
|
21779
Murakami H, Tamura N, Enomoto Y, Shimasaki K, Kurosawa K, Hanada K.
Intellectual disability-associated gain-of-function mutations in CERT1 that encodes the ceramide transport protein CERT.
PLoS One
2020
15(12):e0243980
PubMed ID: 33347465
DOI: 10.1371/journal.pone.0243980
|
Back
Top
CELL BANK Website